Anaplastic Oligodendroglioma (AO) Recruiting Phase 2 Trials for Temozolomide (DB00853)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04623931Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) GlioblastomasTreatment